New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2014
18:03 EDTCECelanese announces intermediate chemistry price increases
Celanese Corporation will increase list and off-list selling prices for Vinyl Acetate Monomer and Acetic Anhydride effective February 1.
News For CE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 13, 2015
06:04 EDTCECelanese sees adjusted EPS of $8.00-$8.50 by 2018
The company expects to generate $2.5B in free cash flow from 2016-2018. It also expects to generate annual synergies that range from $125M-$150M, while constant focus on productivity initiatives is expected to generate $50M-$100M in net productivity savings annually. Celanese will continue to increase its cash dividend, which has grown 50% compounded annually since 2010, and will continue to repurchase shares under the recently announced $1B share repurchase program. The company will outline in more detail the growth objectives and capital allocation plans at its Investor Day.
November 12, 2015
11:34 EDTCECelanese to host investor day
Subscribe for More Information
November 11, 2015
18:03 EDTCE Celanese to add two industrial grades of PEEK to product portfolio in 2016
Subscribe for More Information
17:32 EDTCECelanese to expand acetic acid and VAM capacity in North America
Celanese will expand acetic acid and vinyl acetate monomer capacity in North America. Celanese will implement a series of low capital debottlenecks in its Clear Lake, Texas, acetic acid facility and expects up to 150kt more product. The current nameplate capacity of the facility is 1,350kt per annum. The debottlenecks will happen in stages over the next several years with the expectation that total U.S. output will have a nameplate capacity of more than 1,500kt per annum by 2016. Celanese has also begun work on a 150kt expansion of its Clear Lake, Texas, VAM facility raising plant capacity to 450kt. The expansion will be complete in 2018.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use